1-2 of 2
Authors: Laura Bobolts
Save search
Sort by
Journal Article

The First 2 Years of Biosimilar Epoetin for Cancer and Chemotherapy-Induced Anemia in the U.S.: A Review from the Southern Network on Adverse Reactions

PDF
Charles L. Bennett and others
The Oncologist, Volume 26, Issue 8, August 2021, Pages e1418–e1426, https://doi.org/10.1002/onco.13713
Published: 12 March 2021
Journal Article

Regulatory and Clinical Experiences with Biosimilar Filgrastim in the U.S., the European Union, Japan, and Canada

PDF
Brian Chen and others
The Oncologist, Volume 24, Issue 4, April 2019, Pages 537–548, https://doi.org/10.1634/theoncologist.2018-0341
Published: 06 March 2019